Client News

Splash Beverage Group Names Ron Wall as Chief Financial Officer – Previously Directed Financial Strategy for Global Beverage Company Managing over $500 Million in Revenue

Fort Lauderdale, Florida, April 19, 2022 (GLOBE NEWSWIRE) — Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”), a portfolio company of leading beverage brands, today announced the appointment of Ron Wall as Chief Financial Officer effective May 2nd. Mr. Wall joins Splash Beverage Group with more than 25 years of senior financial […]

Grove Inc. Signs Letter of Intent to Acquire Pet Care Company Through Its Amazon Aggregation Division, Upexi

HENDERSON, NV, April 07, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Grove Inc., (NASDAQ:GRVI) (“Grove” or the “Company”) has signed a letter of intent to acquire a pet care company, offering both grooming and nutrition products through multiple sales channels including business to business, eCommerce and Amazon. Grove aims to expand its product offerings through acquisitions made […]

Splash Beverage Group’s Pulpoloco and Copa di Vino to Be Served at Dodger’s Stadium for 2022 Baseball Season

Splash Beverage Group’s Pulpoloco and Copa di Vino to Be Served at Dodger’s Stadium for 2022 Baseball Season Copa di Vino Splash Beverage Group’s Pulpoloco and Copa di Vino to Be Served at Dodger’s Stadium for 2022 Baseball Season PULPOLOCO Fort Lauderdale, Florida, April 06, 2022 (GLOBE NEWSWIRE) — Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” […]

Longeveron Expands Executive Leadership Team; Appoints K. Chris Min, M.D., Ph.D. as Chief Medical Officer

Dr. Min will lead global clinical development and regulatory strategy MIAMI, April 05, 2022 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and other specific life-threatening conditions, announced today the addition of K. Chris Min, M.D., Ph.D. to the Longeveron executive leadership […]

Sunshine Biopharma’s Newly Designed mRNA Molecules Prove Effective Against Multidrug Resistant Cancer Cells

A Potential Multi-Billion Dollar Global Market Opportunity for Cancer Treatments MONTREAL, April 05, 2022 (GLOBE NEWSWIRE) — Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that two of its newly designed mRNA molecules are effective at destroying cancer cells […]

Pressure BioSciences Leveraging Strong FY2021 Operational and Financial Successes, Worldwide Customer Base, Substantial IP Estate, and Three Powerful Technology Platforms to Accelerate Strategic Company Transformation in 2022

Q4 and FY2021 Total Revenue Increased 91% and 64% Respectfully Over Same Periods in 2020; PCT, BaroFold, and PBI Agrochem Groups Scored Important Gains in 2021; UST Platform Achieved Critical 2021 Goals – Discussions Ongoing with Key Leaders in Multiple Markets Investor Conference Call Scheduled for Tuesday April 5 at 4:30 PM ET SOUTH EASTON, […]

Muscle Maker’s Pokemoto Division Expands in Rhode Island – Five New Agreements Signed

Pokemoto Inks 37 New Franchise Agreements Since November League City, TX, March 29, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Muscle Maker, Inc. (Nasdaq: GRIL), the parent company of Muscle Maker Grill restaurants, Pokemoto Hawaiian Poke and SuperFit Foods meal prep, today announced the signing of five new Pokemoto franchise agreements for Rhode Island. The five additional franchise […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.